Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab

(2022) Andrew Menzies-Gow et al.   ADVANCES IN THERAPY

Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

(2021) Andrew Thamboo et al.   Journal of Otolaryngology-Head & Neck Surgery

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

(2021) Joseph K Han et al.   Lancet Respiratory Medicine

Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis

(2021) Paul Oykhman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease

(2021) Michael Yong et al.   International Forum of Allergy & Rhinology

Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps

(2020) George A. Scangas et al.   LARYNGOSCOPE

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

(2020) Philippe Gevaert et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma

(2020) Ming Wang et al.   Clinical and Translational Allergy

Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis

(2020) Stephanie Chen et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps

(2020) Gayatri B. Patel et al.   ENT-EAR NOSE & THROAT JOURNAL

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps

(2019) Neil Bhattacharyya et al.   LARYNGOSCOPE

EUFOREA Consensus on Biologics for CRS w NP with or without asthma

(2019) W J Fokkens et al.   ALLERGY

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

(2019) Kenneth R. Chapman et al.   ALLERGY

Clinically relevant phenotypes in chronic rhinosinusitis

(2019) Jessica W. Grayson et al.   Journal of Otolaryngology-Head & Neck Surgery

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

(2019) Claus Bachert et al.   LANCET

Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art

(2019) Lei Ren et al.   World Allergy Organization Journal

Discounting in Economic Evaluations

(2018) Arthur E. Attema et al.   PHARMACOECONOMICS

Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations

(2018) R. Brett McQueen et al.   PHARMACOECONOMICS

Medical Expenditures and Earnings Losses Among US Adults With Arthritis in 2013

(2018) Louise B. Murphy et al.   ARTHRITIS CARE & RESEARCH

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors

(2018) Vivek Verma et al.   Journal for ImmunoTherapy of Cancer

Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L)

(2017) R. Trafford Crump et al.   International Forum of Allergy & Rhinology

The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps

(2017) George A. Scangas et al.   International Forum of Allergy & Rhinology

Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease

(2017) Whitney W. Stevens et al.   Journal of Allergy and Clinical Immunology-In Practice

Characterizing Pediatricians' Management of Food Allergy to Improve Care Coordination

(2016) Alana Otto et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis

(2016) Adam S. DeConde et al.   LARYNGOSCOPE

Chronic Rhinosinusitis with Nasal Polyps

(2016) Whitney W. Stevens et al.   Journal of Allergy and Clinical Immunology-In Practice

Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis

(2014) Luke Rudmik et al.   LARYNGOSCOPE

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

(2013) D. Husereau et al.   BMJ-British Medical Journal

Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach

(2013) Jennifer Au et al.   International Forum of Allergy & Rhinology

Quality of Life in Patients with Chronic Rhinosinusitis

(2011) Luke Rudmik et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States

(2011) Dipen A. Patel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Complications in endoscopic sinus surgery for chronic rhinosinusitis

(2011) James A. Stankiewicz et al.   LARYNGOSCOPE

Nationwide incidence of major complications in endoscopic sinus surgery

(2011) Vijay R. Ramakrishnan et al.   International Forum of Allergy & Rhinology

Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States

(2009) Andrew F Smith et al.   BMC Ophthalmology